The data described in this contribution provides a link between the G protein-coupled estrogen receptor 1 (GPER1)-mediated IGFBP-1 accumulation associated with tamoxifen treatment in breast cancer cells (15) with the alteration in growth factor signaling previously reported (17). Here, IGFBP1 is linked to breast cancer.